PAPER
Synthesis of 2-Chlorodifluoromethyl-Substituted Monosaccharides
713
9.3 Hz, H-4), 4.26 (m, 2 H, 3J5,6 = 9.7, 3J5,6 = 4.0 Hz, H-6a, H-6b),
4.09 (dd, 1 H, 3J5,6 = 4.0, 3J5,6 = 9.7 Hz, H-5), 3.76 (s, 1 H, OH, OH-
1), 2.93 (m, 1 H, 3J1,2 = 3.3, 3J2,3 = 11.2 Hz, H-2), 2.08, 2.03, 2.01 (3
s, 9 H, 3 × CH3).
13C NMR (62 MHz, CDCl3): δ = 170.9, 170.0, 169.7 (3 × C=O),
128.1 (t, 1JC,F = 296 Hz, CF2Cl), 90.9 (t, 3JC,F = 4 Hz, C-1), 69.1 (C-
3), 68.5 (C-4), 67.3 (C-6), 62.6 (C-5), 53.6 (t, 2JC,F = 21 Hz, C-2),
20.8, 20.7, 20.6 (3 × CH3).
1H NMR (250 MHz, CDCl3): δ = 6.50 (d, 1 H, 3J1,2 = 3.2 Hz, H-1),
5.62 (dd, 1 H, 3J3,4 = 3.2, 3J2,3 = 11.6 Hz, H-3), 5.33 (m, 1 H, H-4),
3
2
4.01 (dd, 1 H, J4,5a = 1.2, J5a,5b = 13.3 Hz, H-5a), 3.83 (dd, 1 H,
3J4,5b = 2.0, 2J5a,5b = 13.3 Hz, H-5a), 3.12 (m, 1 H, 3J1,2 = 3.2, 3J2,3
11.3 Hz, H-2), 2.15, 2.13, 2.04 (3 s, 9 H, 3 × CH3).
=
13C NMR (62 MHz, CDCl3): δ = 170.1, 169.5, 168.4 (3 × C=O),
127.5 (t, 1JC,F = 296 Hz, CF2Cl), 89.2 (t, 3JC,F = 6 Hz, C-1), 66.8 (C-
2
3), 65.6 (C-4), 62.6 (C-5), 48.0 (t, JC,F = 21 Hz, C-2), 20.9, 20.7,
20.6 (3 × CH3).
19F NMR (235 MHz, CDCl3): δ = –47.1 [d, 2J (Fa,Fb) = 174 Hz, Fa],
–49.1 [d, 2J (Fa,Fb) = 174 Hz, Fb].
19F NMR (235 MHz, CDCl3): δ = –48.4 [d, 2J (Fa,Fb) = 176 Hz, Fa],
–49.3 [d, 2J (Fa,Fb) = 176 Hz, Fb].
Anal. Calcd for C13H17ClF2O8 (374.72): C, 41.67; H, 4.57. Found:
C, 41.66; H, 4.72.
Anal. Calcd for C12H15ClF2O7 (344.70): C, 41.81; H, 4.39. Found:
C, 42.20; H, 4.27.
1,3,4,6-Tetra-O-acetyl-2-chlorodifluoromethyl-2-deoxy- -D-
glucopyranose (4); Typical Procedure
3,4-Di-O-acetyl-2-chlorodifluoromethyl-2-deoxy-D-xylopyra-
nose (9)
Compound 3 (1.12 g, 3.0 mmol) was dissolved in Ac2O (10 mL) at
r.t., followed by dropwise addition of pyridine (10 mL) with stir-
ring. The stirring was continued overnight. Then, the solvents were
evaporated under reduced pressure and the syrupy residue was
purified by column chromatography. For analytical data of the crys-
talline product 4, see Table 1.
3,4-Di-O-acetyl-D-xylal (8; 2.0 g, 10.0 mmol) dissolved in MeCN
(50 mL) and H2O (25 mL) was fluoroalkylated with CF2ClBr (ex-
cess) in the presence of NaHCO3 (5.0 g) and Na2S2O4 (3.48 g, 20
mmol, added in two portions). The procedure was analogous to that
of 2. For analytical data of the crystalline product 9, see Table 1.
1H NMR (300 MHz, CDCl3): δ = 5.75 (dd, 1 H, 3J2,3 = 11.2, 3J3,4
=
=
1H NMR (300 MHz, CDCl3): δ = 5.75 (dd, 1 H, 3J2,3 = 11.1, 3J3,4
=
3
9.3 Hz, H-3), 5.61 (d, 1 H, 3J1,2 = 3.3 Hz, H-1), 5.04 (t, 1 H, 3J3,4
9.4 Hz, H-3), 5.56 (d, 1 H, J1,2 = 3.1 Hz, H-1), 4.94 (m, 1 H,
9.3 Hz, H-4), 4.26 (m, 2 H, 3J5,6 = 9.7, 3J5,6 = 4.0 Hz, H-6a, H-6b),
4.09 (dd, 1 H, 3J5,6 = 4.0, 3J5,6 = 9.7 Hz, H-5), 3.76 (s, 1 H, OH, OH-
1), 2.93 (m, 1 H, 3J1,2 = 3.3, 3J2,3 = 11.2 Hz, H-2), 2.08, 2.03, 2.01 (3
s, 9 H, 3 × CH3).
3J4,5b = 6.2, 3J3,4 = 9.4, 3J4,5a = 10.7 Hz, H-4), 3.91 (dd, 1 H, 3J4,5a
=
10.7, 2J5a,5b = 11.0 Hz, H-5a), 3.79 (dd, 1 H, 3J4,5a = 6.2, 2J5a,5b = 11.0
Hz, H-5b), 3.35 (s, 1 H, OH), 2.85 (m, 1 H, 3J1,2 = 3.1, 3J2,3 = 11.1
Hz, H-2), 2.03, 2.02 (2 s, 6 H, 2 × CH3).
13C NMR (75 MHz, CDCl3): δ = 170.5, 169.5, 169.4, 167.9 (4 ×
C=O), 127,0 (t, 1JC,F = 296 Hz, CF2Cl), 88.4 (t, 3JC,F = 5 Hz, C-1),
69.5 (C-3), 68.3 (C-4), 67.5 (C-5), 61.4 (C-6), 52.4 (t, 2JC,F = 22 Hz,
C-2), 20.6, 20.55, 20.5, 20.4 (4 × CH3).
13C NMR (75 MHz, CDCl3): δ = 170.7, 170.0 (2 × C=O), 127.2 (t,
1JC,F = 297 Hz, CF2Cl), 91.8 (s, C-1), 70.3 (C-3), 67.5 (C-4), 58.9
(C-5), 54.1 (t, 2JC-2,F = 23 Hz, C-2), 21.2, 21.1 (2 × CH3).
19F NMR (235 MHz, CDCl3): δ = –48.8 [d, 2J (Fa,Fb) = 171 Hz, Fa],
19F NMR (235 MHz, CDCl3): δ = –49.1 [d, 2J (Fa,Fb) = 176 Hz, Fa],
–50.1 [d, 2J (Fa,Fb) = 171 Hz, Fb].
–50.4 [d, 2J (Fa,Fb) = 176 Hz, Fb].
Anal. Calcd for C10H13ClF2O6 (302.65): C, 39.68; H, 4.33. Found:
C, 40.14; H, 4.51.
Anal. Calcd for C15H19ClF2O9 (416.76): C, 43.23; H, 4.60. Found:
C, 43.25; H, 4.60.
1,3,4-Tri-O-acetyl-2-chlorodifluoromethyl-2-deoxy- -D-xy-
lopyranoside (10)
Compound 9 (210 mg, 0.69 mmol) was acetylated as described for
4 and the crude product was purified by column chromatography.
For analytical data of the crystalline product 10, see Table 1.
3,4-Di-O-acetyl-2-chlorodifluoromethyl-2-deoxy-D-arabinopy-
ranose (6)
3,4-Di-O-acetyl-D-ribal (5; 2.0 g, 10 mmol) was fluoroalkylated
with CF2ClBr as described for compound 2. However, unlike gluc-
osyl bromide 2 the generated pentosyl bromide was so sensitive to-
wards H2O that it was completely hydrolysed to 6 during workup.
The latter was isolated by column chromatography. For analytical
data of the syrupy product 6, see Table 1.
1H NMR (300 MHz, CDCl3): δ = 5.63 (br s, 1 H, H-1), 5.62 (dd, 1
H, 3J3,4 = 3.3, 3J2,3 = 11.5 Hz, H-3), 5.29 (m, 1 H, 3J4,5a = 1.5 Hz, H-
4), 4.22 (dd, 1 H, 3J4,5a = 1.5, 2J5a,5b = 13.2 Hz, H-5a), 3.72 (dd, 1 H,
3J4,5b = 2.1, 2J5a,5b = 13.2 Hz, H-5a), 3.26 (br s, 1 H, OH), 3.12 (m, 1
H, 3J1,2 = 3.1, 3J2,3 = 11.5 Hz, H-2), 2.14, 2.01 (2 s, 6 H, 2 × CH3).
1H NMR (250 MHz, CDCl3): δ = 6.43 (d, 1 H, 3J1,2 = 3.4 Hz, H-1),
5.73 (dd, 1 H, 3J2,3 = 11.1 Hz, 3J3,4 = 9.4 Hz, H-3), 5.01 (m, 1 H,
3
3
3J3,4 = 9,4 Hz, J4,5 = 6.0 Hz, H-4), 3.91 (dd, 1 H, J4,5a = 6.0 Hz,
2J5a,5b = 11.2 Hz, H-5a), 3.68 (t, 1 H, 2J5a,5b = 11.2 Hz, H-5b), 3.01
(m, 1 H, 3J1,2 = 3.4 Hz, 3J2,3 = 11.1 Hz, H-2), 2.14, 2.05, 2.03 (3 s, 9
H, 3 × CH3).
13C NMR (62 MHz, CDCl3): δ = 169.9, 169.5, 168.3 (3 × C=O),
126.8 (t, 1JC,F = 296 Hz CF2Cl), 88.6 (t, 3JC-1,F = 4.2 Hz, C-1), 69.2
2
(C-3), 67.1 (C-4), 60.4 (C-5), 52.6 (t, JC-2,F = 22 Hz, C-2), 20.8,
13C NMR (75 MHz, CDCl3): δ = 170.4, 169.7 (2 × C=O), 128.5 (t,
1JC,F = 297 Hz, CF2Cl), 91.2 (t, 3JC,F = 6 Hz, C-1), 67.6 (C-3), 65.5
(C-4), 60.7 (C-5), 49.2 (t, 2JC,F = 22 Hz, C-2), 20.9, 20.7 (2 × CH3).
20.7, 20.6 (3 × CH3).
19F NMR (235 MHz, CDCl3): δ = –49.1 [d, 2J (Fa,Fb) = 168 Hz, Fa],
–49.9 [d, 2J (Fa,Fb) = 168 Hz, Fb].
19F NMR (235 MHz, CDCl3): δ = –48.5 [d, 2J (Fa,Fb) = 168 Hz, Fa],
Anal. Calcd for C12H15ClF2O7 (344.69): C, 41.81; H, 4.39. Found:
C, 42.20; H, 4.59.
–49.3 [d, 2J (Fa,Fb) = 168 Hz, Fb].
Anal. Calcd for C10H13ClF2O6 (302.65): C, 39.68; H, 4.33. Found:
C, 39.90; H, 4.51.
3,4-Di-O-acetyl-2-chlorodifluoromethyl-2,6-dideoxy-L-glu-
copyranose (12)
1,3,4-Tri-O-acetyl-2-chlorodifluoromethyl-2-deoxy- -D-ara-
binopyranoside (7)
Compound 6 (1.54 g, 5.09 mmol) was acetylated as described for 4
and the syrupy crude product was purified by column chromatogra-
phy. For analytical data, see Table 1.
Compound 1135 (2.0 g, 9.34 mmol) dissolved in MeCN (50 mL) and
H2O (25 mL) was fluoroalkylated with CF2ClBr (excess) in the
presence of NaHCO3 (5.0 g) and Na2S2O4 (3.48 g, 20 mmol, added
in two portions). The procedure was analogous to the preparation of
2. For analytical data of the crystalline product 12, see Table 1.
Synthesis 2003, No. 5, 707–716 ISSN 0039-7881 © Thieme Stuttgart · New York